Investigating the FLiRT variants of COVID-19: Is it an emerging concern?

被引:5
|
作者
Aden, Durre [1 ]
Zaheer, Sufian [2 ]
机构
[1] Jamia Hamdard, HIMSR, Dept Pathol, New Delhi, India
[2] VMMC, Dept Pathol, New Delhi, India
关键词
COVID-19; FLiRT Variants; Severe acute respiratory syndrome coronavirus; SARS-CoV-2; 2; IMMUNE ESCAPE; SARS-COV-2; TRANSMISSION;
D O I
10.1016/j.prp.2024.155542
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to multiple waves of infections globally. As the virus continues to evolve, new variants have emerged, some with concerning changes in transmissibility and virulence. Among these variants, the "FLiRT Variants" have recently gained attention due to their potential to alter the dynamics of transmission and disease severity. According to the Infectious Disease Society of America, the nickname 'FLiRT' is based on the technical names for their mutations. The FLiRT variants, particularly KP.2, seem to exhibit heightened transmissibility in comparison to earlier Omicron sub-variants. Additionally, they demonstrate a capacity to evade immunity conferred by prior infection and vaccines, although the full extent of this evasion is still being investigated. In this article, we review the characteristics of the FLiRT variants, including their genetic mutations, epidemiological features, potential impact on public health measures, and implications for vaccine efficacy. We also discuss strategies for surveillance, prevention, and mitigation efforts to control the spread of this variant and mitigate its impact on global health.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] COVID-19 Variants and Transfer Learning for the Emerging Stringency Indices
    Ayesha Sohail
    Zhenhua Yu
    Alessandro Nutini
    Neural Processing Letters, 2023, 55 : 2359 - 2368
  • [22] COVID-19 is not the only concern
    Mehta, Manik
    1600, Quartz Business Media Ltd (44): : 8 - 9
  • [23] Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern
    Verena Schöning
    Evangelia Liakoni
    Christine Baumgartner
    Aristomenis K. Exadaktylos
    Wolf E. Hautz
    Andrew Atkinson
    Felix Hammann
    Journal of Translational Medicine, 20
  • [24] Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness
    Shaver, Nicole
    Katz, Melanie
    Asamoah, Gideon Darko
    Linkins, Lori-Ann
    Abdelkader, Wael
    Beck, Andrew
    Bennett, Alexandria
    Hughes, Sarah E.
    Smith, Maureen
    Begin, Mpho
    Coyle, Doug
    Piggott, Thomas
    Kagina, Benjamin M.
    Welch, Vivian
    Colijn, Caroline
    Earn, David J. D.
    El Emam, Khaled
    Heffernan, Jane
    'Brien, Sheila F. O.
    Wilson, Kumanan
    Collins, Erin
    Navarro, Tamara
    Beyene, Joseph
    Boutron, Isabelle
    Bowdish, Dawn
    Cooper, Curtis
    Costa, Andrew
    Curran, Janet
    Griffith, Lauren
    Hsu, Amy
    Grimshaw, Jeremy
    Langlois, Marc-Andre
    Li, Xiaoguang
    Pham-Huy, Anne
    Raina, Parminder
    Rubini, Michele
    Thabane, Lehana
    Wang, Hui
    Xu, Lan
    Brouwers, Melissa
    Horsley, Tanya
    Lavis, John
    Iorio, Alfonso
    Little, Julian
    VACCINE, 2023, 41 (43) : 6411 - 6418
  • [25] Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19
    Linkins, Lori-Ann
    Iorio, Alfonso
    Little, Julian
    Lavis, John
    VACCINE, 2022, 40 (22) : 2986 - 2987
  • [26] Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern
    Schoening, Verena
    Liakoni, Evangelia
    Baumgartner, Christine
    Exadaktylos, Aristomenis K.
    Hautz, Wolf E.
    Atkinson, Andrew
    Hammann, Felix
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [27] Association rules on the COVID-19 variants of concern to guide choices of tourism destinations
    Atsa'am, Donald Douglas
    Wario, Ruth
    CURRENT ISSUES IN TOURISM, 2022, 25 (10) : 1536 - 1540
  • [28] COVID-19 and going concern problem: empirical evidence from an emerging economy
    Md. Rezaul Karim
    Samia Afrin Shetu
    SN Business & Economics, 3 (12):
  • [29] Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology
    Caldwell, Jamie M.
    Le, Xuan
    McIntosh, Lorin
    Meehan, Michael T.
    Ogunlade, Samson
    Ragonnet, Romain
    O'Neill, Genevieve K.
    Trauer, James M.
    McBryde, Emma S.
    PAEDIATRIC RESPIRATORY REVIEWS, 2021, 39 : 32 - 39
  • [30] Covid-19: What new variants are emerging and how are they being investigated?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 372 : n158